Esophagitis

Esophagitis

Receive compensation for participation

Qualified Participants:

  • Male & Female Participants ages 40 years and older
  • Stable dose of atorvastatin > 40 mg QD or rosuvastatin > 20 mg QD (with or without Ezetimibe)
  • CV disease defined as one of the following:
  • ST-elevation MI or non-ST-elevation MI
  • Ischemic Stroke
  • Symptomatic PAD (ABI < 0.85 or amputation due to atherosclerotic disease)

Now at the following site: Uniontown, PA.

Apply to Participate